Nerve ablation reduced blood pressure in two thirds of patients, trial finds
BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k2328 (Published 24 May 2018) Cite this as: BMJ 2018;361:k2328- Jacqui Wise
- London
Renal denervation using ultrasound could prove to be an alternative to lifelong drug treatment for hypertension. Research published in the Lancet shows that the technique significantly reduced systolic blood pressure at two months in patients with hypertension that was resistant to drug treatment.1
The one hour operation uses ultrasound energy to disrupt the nerves between the kidneys and the brain that carry the signals controlling blood pressure.
Radiofrequency ablation of the renal nerves has been investigated previously, with mixed results. A 2017 Cochrane Collaboration meta-analysis found moderate quality …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.